Erasca Foundation

Open & Accessible
Private Foundation
San Diego, CaliforniaSmallEIN: 871300086
Cancer Research CentersCancer Support GroupsHealth CharitiesHuman ServicesDisease Research Institutions

The Erasca Foundation is a corporate foundation established in May 2021 and funded by a donation of 1% of Erasca, Inc.’s capital stock. The foundation funds initiatives aligned with Erasca’s mission such as cancer research, patient advocacy and education, and support for at-risk and underserved populations. Foundation information is presented as a section of Erasca, Inc.’s official website.

Source: Website · Mar 2026

Ideal Applicant

Organizations working in cancer research, patient support/navigation, or health and social services with ties to the life‑sciences sector or to San Diego-area communities; groups that can be introduced through industry or institutional partners.

Good Fit

  • Programs focused on cancer research, clinical trial access, or patient support services.
  • Operational presence in San Diego or established partnerships with San Diego life‑science institutions.
  • Established connections to the life‑sciences industry, hospital systems, or corporate partners.
  • Capacity to receive general operating support and demonstrate measurable patient or community impact.

Geography

Restrictive

Giving is highly California‑focused in the latest year (about 88% of dollars) though a few out‑of‑state grantees appear; the observed footprint spans three states but is primarily local to California.

Recipient Variety

Moderate

The latest year shows 10 grants to 10 distinct recipients, indicating a spread of independent organizations, but the top five recipients accounted for 79% of dollars, so financial concentration exists alongside recipient breadth.

New Applicants

Restrictive

Direct evidence of recipient turnover in 2024 shows many new grantees, but the foundation explicitly declares an invitation‑only/preselected funding policy on its materials; that invitation model combined with high top‑five concentration makes it unlikely an unfamiliar applicant would successfully enter the portfolio.

Source: Zeffy Agent · Mar 2026